Cranberry Enhances Human Immune Function and Reduces Illness
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Healthy Humans
- Sponsor
- University of Florida
- Enrollment
- 54
- Locations
- 1
- Primary Endpoint
- Physiological modifications to immune cell function
- Status
- Completed
- Last Updated
- 14 years ago
Overview
Brief Summary
The purpose of this study is to determine whether consuming a beverage made with cranberry polyphenols and proanthocyanidins is effective in modifying immune function by enhancing immune cell proliferation, cytokine production, and antioxidant capacity. If immune cell proliferation is improved, the subjects are expected to have fewer cold and flu symptoms.
Detailed Description
The study will be conducted as a randomized, double blind, placebo-controlled parallel trial. Subjects will be randomly assigned to either the Treatment (cranberry beverage) group or the Placebo group and each will be instructed to consume the test beverages twice a day for 70 days. The beverage is not commercially prepared juice, but is a beverage prepared with an extract of cranberry that contains polyphenols and proanthocyanidins. Blood is taken at baseline, and day 70. Subjects are given a diary to keep a record of their cold and flu symptoms. Serum is used to determine the antioxidant activity by the ORAC method. Peripheral blood mononuclear cells are isolated from the blood draw and used fresh, cultured for 24 hours or cultured for 10 days. Freshly isolated cells will be used to determine αβ-T, γδ-T, B and NK cell numbers and then cultured in autologous serum for 10 days to determine how well they proliferate. The supernatant of 24 hour cultures will be used for cytokine determination. If cells have been primed by the beverage made with cranberry compounds, the investigators expect the cells to proliferate to a greater extent and have modified cytokine production compared to placebo. If the beverage made with cranberry compounds enhances the proliferation of one or more of these cell types (αβ-T, γδ T, B or NK cell), then it is possible that there will be fewer cold and flu symptoms in the group consuming the cranberry beverage. Incidence of illness is not expected to change, only the severity of the illness.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Health male or non-pregnant female
- •Between the ages of 21 and 50
- •BMI between 18 and 35
Exclusion Criteria
- •High blood pressure define as 140/90
- •Ongoing or chronic illness or infection
- •On hypertensive medication, immunosuppressive drugs, antibiotics, or chronic use of NSAIDS
- •Taking plant-based dietary supplements, antioxidant supplements, or probiotics
- •Vegetarian or strict vegan
- •Consume more than 1 cup of tea (iced or hot) per day
- •Consumes more than 2 glasses of alcoholic beverages per day
- •Consume more than 7 fruits and vegetables per day
Outcomes
Primary Outcomes
Physiological modifications to immune cell function
Time Frame: 70 days
Proliferation of γδ-T cells when cultured ex vivo in autologous serum
Secondary Outcomes
- Cold and flu symptoms(70 days)
- Anti-inflammatory outcome(70 days)